Chronic hepatitis C virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 4, 2015, Pages 742-747

  Caviglia, Gian Paolo ^a   Sciacca, Claudio ^b   Abate, Maria Lorena ^a   Olivero, Antonella ^a   Rosso, Chiara ^a   Touscoz, Giovanni Antonio ^c   Ciancio, Alessia ^a   Rizzetto, Mario ^a   Smedile, Antonina ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CARDINAL MASSAIA HOSPITAL   (Italy)

^c Città della Scienza e della Salute ^*  (Italy)

Author keywords

B cell non Hodgkin lymphoma; Hepatitis C virus; Mixed cryoglobulinemia syndrome; Monoclonal gammopathy of undetermined significance

Indexed keywords

BOCEPREVIR; PEGINTERFERON; RIBAVIRIN; TELAPREVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER PATIENT; CHRONIC ACTIVE HEPATITIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLICULAR LYMPHOMA; HEPATITIS C; HUMAN; LARGE CELL LYMPHOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA; AGE; AGED; COHORT ANALYSIS; COMPLICATION; HEPATITIS C, CHRONIC; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; PREVALENCE; RISK FACTOR;

AGE FACTORS; AGED; COHORT STUDIES; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84924814225     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12837     Document Type: Article

References (26)

1. Peveling-Oberhag J, Arcaini L, Hansmann M-L, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J. Hepatol. 2013; 59: 169-177.
2. Kumada T, Toyoda H, Kiriyama S etal. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients. J. Gastroenterol. Hepatol. 2013; 28: 357-364.
3. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J. Clin. Pathol. 2002; 55: 4-13.
4. Antonelli A, Ferri C, Galeazzi M etal. HCV infection: pathogenesis, clinical manifestations and therapy. Clin. Exp. Rheumatol. 2008; 26: S39-47.
5. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J. Gastrointestin. Liver. Dis. 2007; 16: 65-73.
6. Tawfik NM, El Deeb M, Nasr AS. Monoclonal gammopathy among patients with chronic hepatitis C virus infection. Am. J. Med. Sci. 2013; 345: 366-368.
7. Arcaini L, Vallisa D, Rattotti S etal. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of Fondazione Italiana Linfomi. Ann. Oncol. 2014; 25: 1404-1410.
8. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011; 117: 1792-1798.
9. Santer DM, Ma MM, Hockman D, Landi A, Tyrrell DLJ, Houghton M. Enhanced activation of memory, but not naive, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis. PLoS One 2013; 8: e68308.
10. Kyle RA, Durie BGM, Rajkumar SV etal. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010; 24: 1121-1127.
11. Harris NL, Jaffe ES, Diebold J etal. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol. J. 2000; 1: 53-66.
12. Pellicelli AM, Marignani M, Zoli V etal. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World J. Hepatol. 2011; 3: 278-284.
13. Idilman R, Colantoni A, De Maria N, Alkan S, Nand S, Van Thiel DH. Lymphoproliferative disorders in chronic hepatitis C. J. Viral Hepat. 2004; 11: 302-309.
14. Mangia A, Clemente R, Musto P etal. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. Leukemia 1996; 10: 1209-1213.
15. Andreone P, Zignego AL, Cursaro C etal. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann. Intern. Med. 1998; 129: 294-298.
16. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. Clin. Lymphoma Myeloma 2005; 6: 102-114.
17. Talamini R, Montella M, Crovatto M etal. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int. J. Cancer 2004; 110: 380-385.
18. Mele A, Pulsoni A, Bianco E etal. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996-999.
19. Anderson LA, Pfeiffer R, Warren JL etal. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol. Biomarkers Prev. 2008; 17: 3069-3075.
20. De Sanjose S, Benavente Y, Vajdic CM etal. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin. Gastroenterol. Hepatol. 2008; 6: 451-458.
21. Nieters A, Kallinowski B, Brennan P etal. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006; 131: 1879-1886.
22. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment. Pharmacol. Ther. 2005; 21: 653-662.
23. Hartidge-Lambert SK, Stein EM, Markowitz AJ, Portlock CS. Hepatitis C and non-Hodgkin lymphoma: the clinical perspective. Hepatology 2012; 55: 634-641.
24. Cacoub P, Renou C, Rosenthal E etal. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000; 79: 47-56.
25. Friedman SL. Cellular networks in hepatic fibrosis. Digestion 1998; 59: 368-371.
26. Caviglia GP, Touscoz GA, Smedile A, Pellicano R. Noninvasive assessment of liver fibrosis: key messages for clinicians. Pol. Arch. Med. Wewn. 2014; 124: 329-335.